3B's Research Group, I3B's - Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark 4805-017, Barco, Guimarães, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Jellagen Limited, Unit G6, Capital Business Park, Parkway, St Mellons, Cardiff CF3 2PY, United Kingdom.
Biomater Adv. 2022 Jun;137:212843. doi: 10.1016/j.bioadv.2022.212843. Epub 2022 May 5.
In the recent decade, marine origin products have been growingly studied as building blocks complying with the constant demand of the biomedical sector regarding the development of new devices for Tissue Engineering and Regenerative Medicine (TERM). In this work, several combinations of marine collagen-chitosan-fucoidan hydrogel were formed using a newly developed eco-friendly compressive and absorption methodology to produce hydrogels (CAMPH), which consists of compacting the biopolymers solution while removing the excess of water. The hydrogel formulations were prepared by blending solutions of 5% collagen from jellyfish and/or 3% collagen from blue shark skin, with solutions of 3% chitosan from squid pens and solutions of 10% fucoidan from brown algae, at different ratios. The biopolymer physico-chemical characterization comprised Amino Acid analysis, ATR-FTIR, CD, SDS-PAGE, ICP, XRD, and the results suggested the shark/jellyfish collagen(s) conserved the triple helical structure and had similarities with type I and type II collagen, respectively. The studied collagens also contain a denaturation temperature of around 30-32 °C and a molecular weight between 120 and 125 kDa. Additionally, the hydrogel properties were determined by rheology, water uptake ability, degradation rate, and SEM, and the results showed that all formulations had interesting mechanical (strong viscoelastic character) and structural stability properties, with a significant positive highlight in the formulation of H (blending all biopolymers, i.e., 5% collagen from jellyfish, 3% collagen from skin shark, 3% chitosan and 10% of fucoidan) in the degradation test, that shows a mass loss around 18% over the 30 days, while the H and H, present a mass loss of around 35% and 44%, respectively. Additionally, the in vitro cellular assessments using chondrocyte cells (ATDC5) in encapsulated state revealed, for all hydrogel formulations, a non-cytotoxic behavior. Furthermore, Live/Dead assay and Phalloidin/DAPI staining, to assess the cytoskeletal organization, proved that the hydrogels can provide a suitable microenvironment for cell adhesion, viability, and proliferation, after being encapsulated. Overall, the results show that all marine collagen (jellyfish/shark)-chitosan-fucoidan hydrogel formulations provide a good structural architecture and microenvironment, highlighting the H biomaterial due to containing more polymers in their composition, making it suitable for biomedical articular cartilage therapies.
在最近的十年中,海洋来源的产品作为生物医学领域中组织工程和再生医学(TERM)新设备开发的符合要求的构建块而越来越受到研究。在这项工作中,使用新开发的环保压缩和吸收方法(CAMPH)形成了几种海洋胶原-壳聚糖-褐藻胶水凝胶的组合,该方法包括在除去多余水的同时压缩生物聚合物溶液。水凝胶配方通过将来自水母的 5%胶原和/或来自蓝鲨皮的 3%胶原与来自鱿鱼笔的 3%壳聚糖和来自褐藻的 10%褐藻胶的溶液以不同的比例混合来制备。生物聚合物的物理化学特性包括氨基酸分析,ATR-FTIR,CD,SDS-PAGE,ICP,XRD,结果表明鲨鱼/水母胶原(s)保留了三螺旋结构,并且分别与 I 型和 II 型胶原相似。研究的胶原还包含约 30-32°C 的变性温度和 120 至 125 kDa 之间的分子量。此外,通过流变学,吸水率,降解率和 SEM 来确定水凝胶的性质,结果表明所有配方均具有有趣的机械(强粘弹性)和结构稳定性特性,在 H 配方(混合所有生物聚合物,即 5%来自水母的胶原,3%来自鲨鱼皮的胶原,3%壳聚糖和 10%褐藻胶)的降解试验中表现出明显的积极亮点,表明在 30 天内质量损失约为 18%,而 H 和 H 的质量损失分别约为 35%和 44%。此外,使用包封状态的软骨细胞(ATDC5)进行的体外细胞评估表明,对于所有水凝胶配方,均表现出非细胞毒性行为。此外,使用 Live/Dead 测定法和鬼笔环肽/DAPI 染色来评估细胞骨架组织,证明水凝胶可以在包封后为细胞黏附,活力和增殖提供合适的微环境。总体而言,结果表明所有海洋胶原(水母/鲨鱼)-壳聚糖-褐藻胶水凝胶配方均提供了良好的结构架构和微环境,由于其组成中含有更多的聚合物,因此突出了 H 生物材料,使其适合用于生物医学关节软骨治疗。